BAYERCROP - Bayer CropScience Limited. Share Price

Fertilizers & Agrochemicals

₹5678.30-14.70(-0.26%)

Market Closed as of May 30, 2025, 15:30 IST

Valuation
Market Cap	23.1 kCr
Price/Earnings (Trailing)	34.67
Price/Sales (Trailing)	4.54
EV/EBITDA	24.81
Price/Free Cashflow	29.74
MarketCap/EBT	27.14

Fundamentals
Revenue (TTM)	5.08 kCr
Earnings (TTM)	666.2 Cr

Profitability
Operating Margin	16.75%
EBT Margin	16.75%
Return on Equity	23.38%
Return on Assets	14.49%
Free Cashflow Yield	3.36%

Price to Sales Ratio

Latest reported: ₹5

Revenue (Last 12 mths)

Latest reported: ₹5 kCr

Net Income (Last 12 mths)

Latest reported: ₹666 Cr

Pros

Size: Market Cap wise it is among the top 20% companies of india.

Dividend: Dividend paying stock. Dividend yield of 2.43%.

Momentum: Stock price has a strong positive momentum. Stock is up 19.4% in last 30 days.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Profitability: Recent profitability of 13% is a good sign.

Smart Money: Smart money has been increasing their position in the stock.

Balance Sheet: Strong Balance Sheet.

Technicals: Bullish SharesGuru indicator.

Cons

No major cons observed.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Investor Care
Dividend Yield	2.43%
Dividend/Share (TTM)	125
Shares Dilution (1Y)	0.00%

Financial Health
Current Ratio	2.44
Debt/Equity	0.00
Debt/Cashflow	0.00

Share Holdings

Understand Bayer CropScience ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

As of 2025-03-31

Shareholder Name	Holding %
Bayer Vapi Private Limited	17.89%
Bayer Investments India Private Limited	15.04%
Bayer SAS	14.73%
Bayer CropScience AG	11.91%
Bayer AG	8.43%
Monsanto Company	3.44%
Quant Mutual Fund - Quant Small Cap Fund	2.32%
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund	2.13%
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Frontline Equity Fund	2.03%
Indian Syntans Investments Private Limited	1.04%
Hdfc Life Insurance Company Limited	1.02%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Bayer CropScience Better than it's peers?

Detailed comparison of Bayer CropScience against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
PIIND	PI IndustriesPesticides & Agrochemicals	58.01 kCr	8.26 kCr	+6.15%	+8.20%	34.14	7.02	+7.42%	+6.69%
UPL	UPLPesticides & Agrochemicals	53.02 kCr	45.65 kCr	-5.76%	+21.99%	-156.41	1.16	-1.10%	+52.79%
DHANUKA	Dhanuka AgritechPesticides & Agrochemicals	7.44 kCr	2 kCr	+27.57%	+33.95%	26.54	3.72	+11.46%	+14.30%
SHARDACROP	Sharda CropchemPesticides & Agrochemicals	6.64 kCr	3.85 kCr	+35.91%	+89.04%	27.18	1.73	+13.09%	+179.92%
RALLIS	Rallis IndiaPesticides & Agrochemicals	6.22 kCr	2.7 kCr	+20.67%	+10.37%	45.77	2.31	-1.93%	+36.18%

Sector Comparison: BAYERCROP vs Fertilizers & Agrochemicals

Comprehensive comparison against sector averages

Comparative Metrics

BAYERCROP metrics compared to Fertilizers

Category	BAYERCROP	Fertilizers
PE	34.67	56.03
PS	4.54	2.43
Growth	-3.8 %	4.3 %

Performance Comparison

BAYERCROP vs Fertilizers (2021 - 2025)

Key Insights

1. BAYERCROP is among the Top 5 Pesticides & Agrochemicals companies by market cap.
2. The company holds a market share of 6% in Pesticides & Agrochemicals.
3. In last one year, the company has had a below average growth that other Pesticides & Agrochemicals companies.

Income Statement for Bayer CropScience

Standalone figures (in Rs. Crores)

QuarterlyAnnual

Description	(%) Q/Q	Jun-2024	Mar-2024	Dec-2023	Sep-2023	Jun-2023	Mar-2023
Revenue From Operations	106.1%	1,631	792	955	1,617	1,740	982
Other Income	-6.9%	28	30	15	16	21	21
Total Income	102.2%	1,659	821	970	1,633	1,760	1,003
Cost of Materials	61.6%	846	524	364	934	897	650
Purchases of stock-in-trade	66.7%	51	31	17	33	58	87
Employee Expense	-21.4%	100	127	114	101	93	132
Finance costs	-17.9%	4.2	4.9	3.1	3.7	7.9	7.3
Depreciation and Amortization	40%	22	16	15	12	31	27
Other expenses	22.1%	233	191	185	202	224	163
Total Expenses	87.7%	1,343	716	845	1,328	1,354	811
Profit Before exceptional items and Tax	202.9%	316	105	124	306	406	192
Exceptional items before tax	-	0	0	0	0	0	3.1
Total profit before tax	202.9%	316	105	124	306	406	195
Current tax	490%	60	11	31	81	75	35
Deferred tax	106.9%	1.2	-1.9	0.2	2	2.2	1.5
Total tax	626.2%	62	9.4	31	83	78	37
Total profit (loss) for period	166.3%	254	96	93	223	328	158
Other comp. income net of taxes	-144.4%	-0.2	3.7	-2.9	1.4	1.3	1.9
Total Comprehensive Income	155.6%	254	100	90	224	330	160
Earnings Per Share, Basic	172.9%	56.56	21.36	20.72	49.6	73.09	35.27
Earnings Per Share, Diluted	172.9%	56.56	21.36	20.72	49.6	73.09	35.27

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Revenue From Operations	-0.7%	5,103	5,140	4,734	4,261	3,609	2,686
Other Income	27%	81	64	55	64	66	37
Total Income	-0.4%	5,184	5,204	4,789	4,325	3,675	2,723
Cost of Materials	6.9%	2,718	2,542	2,578	2,484	1,751	1,383
Purchases of stock-in-trade	-50%	139	277	230	140	99	106
Employee Expense	-18.6%	435	534	463	362	362	321
Finance costs	-9.5%	20	22	13	13	14	9.9
Depreciation and Amortization	-7.6%	74	80	64	74	65	34
Other expenses	-7.3%	802	865	796	642	612	505
Total Expenses	-1.7%	4,243	4,317	4,001	3,536	2,962	2,357
Profit Before exceptional items and Tax	6.2%	941	886	788	789	713	366
Exceptional items before tax	-101%	0	104	58	5.1	-130.2	0
Total profit before tax	-5%	941	990	847	794	583	366
Current tax	-10.5%	198	221	192	294	125	134
Deferred tax	-85%	2.5	11	9.6	7.5	-16.2	-5.4
Total tax	-13.4%	201	232	202	301	109	129
Total profit (loss) for period	-2.4%	740	758	645	493	474	238
Other comp. income net of taxes	126%	3.5	-8.6	2.9	1.6	-18.2	-58
Total Comprehensive Income	-0.8%	744	750	648	495	456	180
Earnings Per Share, Basic	-2.3%	164.77	168.71	143.58	109.72	105.58	69.2
Earnings Per Share, Diluted	-2.3%	164.77	168.71	143.58	109.72	105.58	69.2

Balance Sheet for Bayer CropScience

Standalone figures (in Rs. Crores)

Description	(%) Q/Q	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022	Sep-2021
Cash and cash equivalents	129.4%	1,157	505	861	574	781	879
Current investments	26.2%	54	43	41	39	38	38
Total current financial assets	-15.9%	2,186	2,600	1,894	2,293	1,841	2,358
Inventories	-2%	1,545	1,577	1,807	1,252	1,512	1,212
Total current assets	-12.2%	3,906	4,450	3,896	3,827	3,576	3,864
Property, plant and equipment	-6%	376	400	428	429	437	389
Capital work-in-progress	-5.3%	6.4	6.7	2.9	14	13	8.3
Investment property	0%	25	25	26	26	26	30
Total non-current financial assets	-19.5%	7.2	8.7	5.4	6.7	6.8	14
Total non-current assets	-9.3%	692	763	782	788	777	735
Total assets	-11.8%	4,597	5,214	4,679	4,630	4,353	4,599
Total non-current financial liabilities	25%	21	17	36	47	52	18
Provisions, non-current	7.8%	125	116	152	96	118	95
Total non-current liabilities	8.8%	150	138	189	142	169	113
Borrowings, current	-	0	0	0	0	0	0
Total current financial liabilities	-1.5%	680	690	955	549	899	714
Provisions, current	-19%	52	64	113	98	110	72
Current tax liabilities	-98.7%	1.9	68	2.9	66	16	70
Total current liabilities	-17.9%	1,597	1,944	1,778	1,601	1,659	1,640
Total liabilities	-16%	1,748	2,082	1,966	1,751	1,829	1,753
Equity share capital	0%	45	45	45	45	45	45
Total equity	-9%	2,849	3,131	2,712	2,879	2,524	2,846
Total equity and liabilities	-11.8%	4,597	5,214	4,679	4,630	4,353	4,599

Cash Flow for Bayer CropScience

Standalone figures (in Rs. Crores)

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Finance costs	-9.5%	20	22	13
Change in inventories	157.4%	207	-357.9	-236.4
Depreciation	-7.6%	74	80	64
Impairment loss / reversal	-	16	0	0
Unrealised forex losses/gains	-550%	-0.3	0.8	-0.5
Adjustments for interest income	56%	40	26	20
Net Cashflows from Operations	27.7%	1,084	849	480
Income taxes paid (refund)	-45.2%	132	240	264
Net Cashflows From Operating Activities	56.4%	952	609	216
Proceeds from sales of PPE	40.5%	6.2	4.7	8.1
Purchase of property, plant and equipment	-25.6%	33	44	34
Proceeds from sales of intangible assets	-	0.1	0	0
Purchase of intangible assets	-64.9%	3.7	8.7	5.5
Purchase of intangible assets under development	-64.8%	9.1	24	16
Interest received	20.8%	30	25	20
Other inflows (outflows) of cash	-18.3%	7.7	9.2	7
Net Cashflows From Investing Activities	-100.7%	0.4	83	64
Payments of lease liabilities	2.5%	42	41	26
Dividends paid	8.2%	607	561	673
Interest paid	-32%	7.8	11	4.2
Net Cashflows from Financing Activities	-7%	-656.3	-613.2	-703.3
Effect of exchange rate on cash eq.	-40%	0.3	0.5	0
Net change in cash and cash eq.	273.4%	296	80	-423.6

What does Bayer CropScience Limited. do?

Pesticides & Agrochemicals•Chemicals•Small Cap

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRise and other digital applications, such as drones for spray services, etc., as well as provides various technologies, such as remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to monitor and manage crop growth, soil quality, weather patterns, and other factors. The company also exports its products. Bayer CropScience Limited was founded in 1863 and is based in Thane, India.

Industry Group:Fertilizers & Agrochemicals

Employees:1,317

Website:www.bayer.in

BAYERCROP - Bayer CropScience Limited. Share Price

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Investor Care

Financial Health

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Bayer CropScience Limited. do?